Clinical Cancer Research Joint Metastasis Research Society-AACR Conference on Metastasis Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bon, G.
Right arrow Articles by Falcioni, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bon, G.
Right arrow Articles by Falcioni, R.
Clinical Cancer Research Vol. 12, 3280-3287, June 1, 2006
© 2006 American Association for Cancer Research


Human Cancer Biology

Loss of ß4 Integrin Subunit Reduces the Tumorigenicity of MCF7 Mammary Cells and Causes Apoptosis upon Hormone Deprivation

Giulia Bon1, Valentina Folgiero1, Gianluca Bossi1, Laura Felicioni2, Antonio Marchetti2, Ada Sacchi1 and Rita Falcioni1

Authors' Affiliations: 1 Molecular Oncogenesis Laboratory, Department of Experimental Oncology, Regina Elena Cancer Institute, Rome, Italy and 2 Clinical Research Center, Center of Excellence on Aging, University-Foundation, Chieti, Italy

Requests for reprints: Rita Falcioni, Regina Elena Cancer Institute, Department of Experimental Oncology, Molecular Oncogenesis Laboratory, Via delle Messi d'Oro, 156, 00158 Rome, Italy. Phone: 39-06-52662535; Fax: 39-06-52662505; E-mail: falcioni{at}ifo.it.

Purpose: The {alpha}6ß4 integrin, a laminin receptor, has been implicated from many studies in tumor progression and invasion. We showed that the ß4 integrin subunit associates with the ErbB-2 tyrosine kinase in human mammary carcinoma cell lines and that its overexpression in NIH3T3/ErbB-2–transformed cells causes a constitutive activation of phosphatidylinositol 3-kinase (PI3K), inducing a strong increase of their invasive capacity. In this study, we investigated the biological consequences of interference with the endogenous ß4 integrin subunit expression.

Experimental Design: In vitro and in vivo tumor growth and the biochemical consequences of ß4 integrin inactivation were studied in mammary tumor cells by using short hairpin RNA approach.

Results: Our data show that tumor growth of mammary tumor cells strictly depends on ß4 expression, confirming the relevance of ß4 protein in these cells. Moreover, interference with ß4 expression significantly reduces endogenous PI3K activity and AKT and mammalian target of rapamycin phosphorylation. Accordingly, with these results and considering that PI3K activity in mammary tumor plays a relevant role in hormone resistance, we asked whether ß4 expression might be relevant for hormone responsiveness in these cells. Data reported indicate that the interference with endogenous ß4 expression, upon hormone deprivation, induces caspase-9 and cytochrome c–mediated apoptosis, which is enhanced upon tamoxifen treatment. On the other hand, the expression of myr-AKT in MCF7 ß4–short hairpin RNA cells rescues the cells from apoptosis in the absence of hormones and upon tamoxifen treatment.

Conclusions: Overall, these results confirm the relevance of ß4 expression in mammary tumors and indicate this integrin as a relevant target for tumor therapy.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Dentelli, A. Rosso, A. Zeoli, R. Gambino, L. Pegoraro, G. Pagano, R. Falcioni, and M. F. Brizzi
Oxidative Stress-mediated Mesangial Cell Proliferation Requires RAC-1/Reactive Oxygen Species Production and beta4 Integrin Expression
J. Biol. Chem., September 7, 2007; 282(36): 26101 - 26110.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. Tian, C.-h. Zhu, X.-w. Zhang, X. Xie, X.-l. Xin, Y.-h. Yi, L.-p. Lin, M.-y. Geng, and J. Ding
Philinopside E, a New Sulfated Saponin from Sea Cucumber, Blocks the Interaction between Kinase Insert Domain-Containing Receptor (KDR) and {alpha}vbeta3 Integrin via Binding to the Extracellular Domain of KDR
Mol. Pharmacol., September 1, 2007; 72(3): 545 - 552.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Folgiero, R. E. Bachelder, G. Bon, A. Sacchi, R. Falcioni, and A. M. Mercurio
The {alpha}6{beta}4 Integrin Can Regulate ErbB-3 Expression: Implications for {alpha}6{beta}4 Signaling and Function
Cancer Res., February 15, 2007; 67(4): 1645 - 1652.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
B. Hegedus, F. Marga, K. Jakab, K. L. Sharpe-Timms, and G. Forgacs
The Interplay of Cell-Cell and Cell-Matrix Interactions in the Invasive Properties of Brain Tumors
Biophys. J., October 1, 2006; 91(7): 2708 - 2716.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.